Identification of Potential LncRNAs and MiRNAs As Diagnostic Biomarkers for Papillary Thyroid Carcinoma Based on Machine Learning

Overview

Journal Int J Endocrinol

Publisher Wiley

Specialty Endocrinology

Date 2021 Aug 2

PMID 34335744

Citations 15

Authors

Fei Yang

Jie Zhang

Baokun Li

Zhijun Zhao

Yan Liu

Zhen Zhao

Shanghua Jing

Guiying Wang

Affiliations

Soon will be listed here.

Abstract

Background: Papillary thyroid carcinoma (PTC) accounts for most of the proportion of thyroid cancer (TC). The objective of this study was to identify diagnostic, differentially expressed long noncoding RNAs (lncRNAs) and microRNAs (miRNAs), contributing to understanding the epigenetics mechanism of PTC.

Methods: The data of lncRNA, miRNA, and mRNA were downloaded from the Cancer Genome Atlas (TCGA) dataset, followed by functional analysis of differentially expressed mRNAs. Optimal diagnostic lncRNA and miRNA biomarkers were identified via random forest. The regulatory network between optimal diagnostic lncRNA and mRNAs and optimal diagnostic miRNA and mRNAs was identified, followed by the construction of ceRNA network of lncRNA-mRNA-miRNA. Expression validation and diagnostic analysis of lncRNAs, miRNAs, and mRNAs were performed. Overexpression of ADD3-AS1 was performed in PTC-UC3 cell lines, and cell proliferation and invasion assay were used for investigating the role of ADD3-AS1 in PTC.

Results: A total of 107 differentially expressed lncRNAs, 81 differentially expressed miRNAs, and 515 differentially expressed mRNAs were identified. 11 lncRNAs and 6 miRNAs were regarded as the optimal diagnostic biomarkers for PTC. The epigenetic modifications via the above diagnostic lncRNAs and miRNAs were identified, including MIR181A2HG-FOXP2-hsa-miR-146b-3p, BLACAT1/ST7-AS1-RPS6KA5-hsa-miR-34a-5p, LBX2-AS1/MIR100HG-CDHR3-hsa-miR-34a-5p, ADD3-AS1-PTPRE-hsa-miR-9-5p, ADD3-AS1-TGFBR1-hsa-miR-214-3p, LINC00506-MMRN1-hsa-miR-4709-3p, and LOC339059-STK32A-hsa-miR-199b-5p. In the functional analysis, MMRN1 and TGFBR1 were involved in cell adhesion and endothelial cell migration, respectively. Overexpression of ADD3-AS1 inhibited cell growth and invasion in PTC cell lines.

Conclusion: The identified lncRNAs/miRNAs/mRNA were differentially expressed between normal and cancerous tissues. In addition, identified altered lncRNAs and miRNAs may be potential diagnostic biomarkers for PTC. Additionally, epigenetic modifications via the above lncRNAs and miRNAs may be involved in tumorigenesis of PTC.

Citing Articles

Subtype cluster analysis unveiled the correlation between m6A- and cuproptosis-related lncRNAs and the prognosis, immune microenvironment, and treatment sensitivity of esophageal cancer.

Zhang M, Su Y, Wen P, Shao X, Yang P, An P Front Immunol. 2025; 16:1539630.

PMID: 40034693 PMC: 11872909. DOI: 10.3389/fimmu.2025.1539630.

Could microRNA Analysis Help in the Management of Medullary Thyroid Cancer?.

Febrero B, Ros-Madrid I, Revilla-Nuin B, Abellan M, Ruiz-Manzanera J, Gomez J Cancers (Basel). 2025; 17(4).

PMID: 40002224 PMC: 11853104. DOI: 10.3390/cancers17040629.

Holomics and Artificial Intelligence-Driven Precision Oncology for Medullary Thyroid Carcinoma: Addressing Challenges of a Rare and Aggressive Disease.

Luvhengo T, Moeng M, Sishuba N, Makgoka M, Jonas L, Mamathuntsha T Cancers (Basel). 2024; 16(20).

PMID: 39456563 PMC: 11505703. DOI: 10.3390/cancers16203469.

LncRNA ZFAS1 promotes invasion of medullary thyroid carcinoma by enhancing EPAS1 expression via miR-214-3p/UCHL1 axis.

Chen W, Wang S, Wei D, Zhai L, Liu L, Pan C J Cell Commun Signal. 2024; 18(2):e12021.

PMID: 38946718 PMC: 11208124. DOI: 10.1002/ccs3.12021.

Long Non-Coding RNA LOC339059 Attenuates IL-6/STAT3-Signaling-Mediated PDL1 Expression and Macrophage M2 Polarization by Interacting with c-Myc in Gastric Cancer.

Han H, Ding G, Wang S, Meng J, Lv Y, Yang W Cancers (Basel). 2023; 15(22).

PMID: 38001573 PMC: 10670112. DOI: 10.3390/cancers15225313.

References

He H, Jazdzewski K, Li W, Liyanarachchi S, Nagy R, Volinia S . The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci U S A. 2005; 102(52):19075-80. PMC: 1323209. DOI: 10.1073/pnas.0509603102. View

de la Chapelle A, Jazdzewski K . MicroRNAs in thyroid cancer. J Clin Endocrinol Metab. 2011; 96(11):3326-36. PMC: 3410255. DOI: 10.1210/jc.2011-1004. View

Zhang Y, Zhong Q, Chen X, Fang J, Huang Z . Diagnostic value of microRNAs in discriminating malignant thyroid nodules from benign ones on fine-needle aspiration samples. Tumour Biol. 2014; 35(9):9343-53. DOI: 10.1007/s13277-014-2209-1. View

Goedert L, Placa J, Fuziwara C, Machado M, Placa D, Almeida P . Identification of Long Noncoding RNAs Deregulated in Papillary Thyroid Cancer and Correlated with BRAF Mutation by Bioinformatics Integrative Analysis. Sci Rep. 2017; 7(1):1662. PMC: 5431778. DOI: 10.1038/s41598-017-01957-0. View

Silvera S, Miller A, Rohan T . Risk factors for thyroid cancer: a prospective cohort study. Int J Cancer. 2005; 116(3):433-8. DOI: 10.1002/ijc.21079. View

Ander B, Barger N, Stamova B, Sharp F, Schumann C . Atypical miRNA expression in temporal cortex associated with dysregulation of immune, cell cycle, and other pathways in autism spectrum disorders. Mol Autism. 2015; 6:37. PMC: 4491207. DOI: 10.1186/s13229-015-0029-9. View

Peterson E, De P, Nuttall R . BMI, diet and female reproductive factors as risks for thyroid cancer: a systematic review. PLoS One. 2012; 7(1):e29177. PMC: 3261873. DOI: 10.1371/journal.pone.0029177. View

Lowe S, Lin A . Apoptosis in cancer. Carcinogenesis. 2000; 21(3):485-95. DOI: 10.1093/carcin/21.3.485. View

Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, Jemal A . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6):394-424. DOI: 10.3322/caac.21492. View

10.

Tetzlaff M, Liu A, Xu X, Master S, Baldwin D, Tobias J . Differential expression of miRNAs in papillary thyroid carcinoma compared to multinodular goiter using formalin fixed paraffin embedded tissues. Endocr Pathol. 2007; 18(3):163-73. DOI: 10.1007/s12022-007-0023-7. View

11.

Liu C, Feng Z, Chen T, Lv J, Liu P, Jia L . Downregulation of NEAT1 reverses the radioactive iodine resistance of papillary thyroid carcinoma cell via miR-101-3p/FN1/PI3K-AKT signaling pathway. Cell Cycle. 2019; 18(2):167-203. PMC: 6343742. DOI: 10.1080/15384101.2018.1560203. View

12.

Li S, Yin Y, Yu H . Genetic expression profile-based screening of genes and pathways associated with papillary thyroid carcinoma. Oncol Lett. 2018; 16(5):5723-5732. PMC: 6176351. DOI: 10.3892/ol.2018.9342. View

13.

Sakuma T, Barry M, Ikeda Y . Lentiviral vectors: basic to translational. Biochem J. 2012; 443(3):603-18. DOI: 10.1042/BJ20120146. View

14.

Huang P, Lin Y, Chi H, Chen P, Huang Y, Yeh C . Thyroid hormone inhibits growth of hepatoma cells through induction of miR-214. Sci Rep. 2017; 7(1):14868. PMC: 5665905. DOI: 10.1038/s41598-017-14864-1. View

15.

Song H, Liu D, Dong S, Zeng L, Wu Z, Zhao P . Epitranscriptomics and epiproteomics in cancer drug resistance: therapeutic implications. Signal Transduct Target Ther. 2020; 5(1):193. PMC: 7479143. DOI: 10.1038/s41392-020-00300-w. View

16.

Kesherwani V, Shukla M, Coulter D, Sharp J, Joshi S, Chaturvedi N . Long non-coding RNA profiling of pediatric Medulloblastoma. BMC Med Genomics. 2020; 13(1):87. PMC: 7318516. DOI: 10.1186/s12920-020-00744-7. View

17.

Wang S, Ke H, Zhang H, Ma Y, Ao L, Zou L . LncRNA MIR100HG promotes cell proliferation in triple-negative breast cancer through triplex formation with p27 loci. Cell Death Dis. 2018; 9(8):805. PMC: 6057987. DOI: 10.1038/s41419-018-0869-2. View

18.

Shearer R, Saunders D . Experimental design for stable genetic manipulation in mammalian cell lines: lentivirus and alternatives. Genes Cells. 2014; 20(1):1-10. DOI: 10.1111/gtc.12183. View

19.

Pellegriti G, Frasca F, Regalbuto C, Squatrito S, Vigneri R . Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol. 2013; 2013:965212. PMC: 3664492. DOI: 10.1155/2013/965212. View

20.

Liu J, Zhu Y, Ge C . LncRNA ZFAS1 promotes pancreatic adenocarcinoma metastasis via the RHOA/ROCK2 pathway by sponging miR-3924. Cancer Cell Int. 2020; 20:249. PMC: 7298847. DOI: 10.1186/s12935-020-01322-8. View